Atıf İçin Kopyala
Aka S., Abali S., Taskin A., Bengur F. B., Semiz S.
Acta endocrinologica (Bucharest, Romania : 2005), cilt.16, sa.4, ss.402-408, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
16
Sayı:
4
-
Basım Tarihi:
2020
-
Doi Numarası:
10.4183/aeb.2020.402
-
Dergi Adı:
Acta endocrinologica (Bucharest, Romania : 2005)
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
-
Sayfa Sayıları:
ss.402-408
-
Anahtar Kelimeler:
Early puberty, GnRH analog treatment, Triptorelin acetate, Leuprolide acetate, body mass index, final height, BODY-MASS INDEX, CENTRAL PRECOCIOUS PUBERTY, GONADOTROPIN-SUPPRESSIVE THERAPY, ADULT HEIGHT, HORMONE ANALOGS, GROWTH, REFERENCES, AGONISTS, PATTERN, WEIGHT
-
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli:
Evet
Özet
Context. GnRHa treatment has been a standard of care in progressive early puberty (EP). Choice of the GnRHa formulation is dependent on the preference of the clinician.